MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0067152
Stemgrow Pharmaceuticals Private Limited
Stemgrow Pharmaceuticals Private Limited - chemicals in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹51.86 Lakh
▲ 300% YoY
Net profit · FY 2024
₹1.33 Lakh
Net margin 2.6%
EBITDA · FY 2024
₹2.59 Lakh
EBITDA margin 5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About Stemgrow Pharmaceuticals Private Limited
Data last updated:
Stemgrow Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 15 June 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2022PTC163671. Its GSTIN is 36ABICS7375Q1ZA (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Srikanth Sankati and Ramesh Gogulakonda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹51.86 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.33 Lakh (net margin 2.6%) and EBITDA of ₹2.59 Lakh (EBITDA margin 5%).
Stemgrow Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0067152).
Company details
CIN U51909TG2022PTC163671
Registration Number 163671
Incorporation Date 15 June 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0067152
Recognitions & Rankings of Stemgrow Pharmaceuticals
Contact details
Stemgrow Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 11 – 5 – 507 Sri Venkateswara Colony, Opp To Municipal Office Road No 16, Hyderabad, Telangana, India – 500035
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Stemgrow Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Stemgrow Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Stemgrow Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Stemgrow Pharmaceuticals Private Limited, buy the company report.
Financials of Stemgrow Pharmaceuticals Private Limited
FY 2025 filings availableStemgrow Pharmaceuticals Private Limited reported revenue of ₹51.86 Lakh (up 300% YoY) for FY 2024.
Revenue · FY 2024
₹51.86 Lakh ▲ 300%
Net profit · FY 2024
₹1.33 Lakh margin 2.6%
EBITDA · FY 2024
₹2.59 Lakh margin 5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 300%
Revenue rose 300% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹2.59 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹1.33 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5% | |
| Net Profit Margin | 2.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Stemgrow Pharmaceuticals Private Limited, buy the company report.
Board of directors of Stemgrow Pharmaceuticals Private Limited
Stemgrow Pharmaceuticals has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srikanth Sankati Also directs: Venshield Healthcare Private Limited | Director | 21 Mar 2024 | 2 Years 7 Months | Current |
| Ramesh Gogulakonda | Director | 21 Mar 2024 | 2 Years 7 Months | Current |
| Gopalreddy Busireddy Also directs: Venshield Healthcare Private Limited | Director | 21 Mar 2024 | 2 Years 7 Months | Current |
| Mahesh Chiguru | Director | 21 Mar 2024 | 2 Years 7 Months | Current |
| Shivakumar Pasula | Director | 15 Jun 2022 | 4 Years 4 Months | Current |
Peer comparison
Stemgrow Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bioziv Healthcare Private Limited | ₹51.99 Lakh (FY 2024) | -23.0% | Manimajra, Chandigarh, India | |||
| Novomax Pharma Private Limited | ₹51.88 Lakh (FY 2024) | 90.0% | New Delhi, Delhi, India | |||
| Stemgrow Pharmaceuticals Private Limitedthis company | ₹51.86 Lakh (FY 2024) | ₹1.33 Lakh | 2.6% | 300.0% | Hyderabad, Telangana, India | |
| Axxontis Biopharmaceuticals Private Limited | ₹51.65 Lakh (FY 2024) | -1.0% | Hoshiarpur, Punjab, India | |||
| Suraj Remedies Private Limited | ₹51.48 Lakh (FY 2025) | -54.0% | Uttar Pradesh, India | |||
| Belida Pharmaceuticals Private Limited | ₹51.47 Lakh (FY 2025) | 73.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Stemgrow Pharmaceuticals Private Limited, buy the company report.
Auditor
Stemgrow Pharmaceuticals Private Limited is audited by SRINATHCHANDANALA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SRINATHCHANDANALA | FY 2023 | 240358 |
Shareholding
The shareholding of Stemgrow Pharmaceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Stemgrow Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Stemgrow Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stemgrow Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Stemgrow Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
Active EPFO establishments
1
GST
Stemgrow Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABICS7375Q1ZA | Telangana | Active | 06 Oct 2022 |
To see the full GST registrations and return filing status of Stemgrow Pharmaceuticals Private Limited, buy the company report.
Recent activity
Stemgrow Pharmaceuticals Private Limited has 10 board changes on record since 2022: 5 appointments and 5 cessations. The latest: Gopalreddy Busireddy ceased to be Additional Director on 29 Sep 2024.
AGM
Stemgrow Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stemgrow Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Gopalreddy Busireddy ceased to be Additional Director.
Ceased
Mahesh Chiguru ceased to be Additional Director.
Ceased
Ramesh Gogulakonda ceased to be Additional Director.
Ceased
Srikanth Sankati ceased to be Additional Director.
Ceased
Naresh Kummari ceased to be Director.
Appointed
Gopalreddy Busireddy was appointed as Director.
Appointed
Mahesh Chiguru was appointed as Director.
Appointed
Ramesh Gogulakonda was appointed as Director.
Appointed
Srikanth Sankati was appointed as Director.
Appointed
Shivakumar Pasula was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Stemgrow Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 15 June 2022 (4+ years old) and is registered under CIN U51909TG2022PTC163671.
Stemgrow Pharmaceuticals has 5 current directors:
- Srikanth Sankati - Director
- Ramesh Gogulakonda - Director
- Gopalreddy Busireddy - Director
- Mahesh Chiguru - Director
- Shivakumar Pasula - Director
The latest financial statements of Stemgrow Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Stemgrow Pharmaceuticals is 36ABICS7375Q1ZA, registered in Telangana.
The CIN (Corporate Identification Number) of Stemgrow Pharmaceuticals is U51909TG2022PTC163671. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stemgrow Pharmaceuticals was incorporated on 15 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Stemgrow Pharmaceuticals by revenue are Bioziv Healthcare Private Limited, Novomax Pharma Private Limited, Axxontis Biopharmaceuticals Private Limited, Suraj Remedies Private Limited, Belida Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Gopalreddy Busireddy ceased to be Additional Director on 29 Sep 2024. Mahesh Chiguru ceased to be Additional Director on 29 Sep 2024. Ramesh Gogulakonda ceased to be Additional Director on 29 Sep 2024. Stemgrow Pharmaceuticals has 10 board changes on record in total.
Yes, Stemgrow Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0067152).
The registered office of Stemgrow Pharmaceuticals is at H.No. 11 – 5 – 507 Sri Venkateswara Colony, Opp To Municipal Office Road No 16, Hyderabad, Telangana, India – 500035.
Stemgrow Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages